News
BDSX
21.99
-10.24%
-2.51
Can Elevance Recover $115 Million Through Its CMS Lawsuit?
NASDAQ · 1d ago
Weekly Report: what happened at BDSX last week (0622-0626)?
Weekly Report · 5d ago
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
NASDAQ · 5d ago
Biodesix Initiated at Buy by Roth Capital
Dow Jones · 06/25 11:08
Roth starts Biodesix at Buy, says positioned to deliver durable growth
TipRanks · 06/24 22:25
Weekly Report: what happened at BDSX last week (0615-0619)?
Weekly Report · 06/22 10:20
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
NASDAQ · 06/19 14:23
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?
NASDAQ · 06/19 08:27
Biodesix Is Maintained at Buy by Canaccord Genuity
Dow Jones · 06/18 13:26
Biodesix Price Target Raised to $27.00/Share From $22.00 by Canaccord Genuity
Dow Jones · 06/18 13:26
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $27
Benzinga · 06/18 13:17
Biodesix price target raised to $27 from $22 at Canaccord
TipRanks · 06/18 10:55
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
Reuters · 06/18 07:14
BIODESIX INC <BDSX.O>: CANACCORD GENUITY RAISES TARGET PRICE TO $27 FROM $22
Reuters · 06/18 05:58
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga · 06/15 13:15
Biodesix Initiated at Buy by HC Wainwright & Co.
Dow Jones · 06/15 10:27
Biodesix Price Target Announced at $26.00/Share by HC Wainwright & Co.
Dow Jones · 06/15 10:27
Weekly Report: what happened at BDSX last week (0608-0612)?
Weekly Report · 06/15 10:21
HC Wainwright & Co. Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $26
Benzinga · 06/15 10:17
Biodesix initiated with a Buy at H.C. Wainwright
TipRanks · 06/15 10:15
More
Webull provides a variety of real-time BDSX stock news. You can receive the latest news about BIODESIX INC through multiple platforms. This information may help you make smarter investment decisions.
About BDSX
Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.